12/22
02:07 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/14
02:01 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/12
08:17 am
vnrx
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants [Yahoo! Finance]
Medium
Report
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants [Yahoo! Finance]
12/12
08:00 am
vnrx
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
High
Report
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
12/10
09:44 am
vnrx
VolitionRx Limited (NYSE: VNRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.
12/10
08:14 am
vnrx
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening [Yahoo! Finance]
High
Report
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening [Yahoo! Finance]
12/10
08:00 am
vnrx
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening
Low
Report
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening
12/6
09:00 am
vnrx
VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering
High
Report
VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering
12/6
02:17 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/28
03:03 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/22
09:41 am
vnrx
VolitionRx Limited (NYSE: VNRX) had its "hold" rating re-affirmed by analysts at Benchmark Co..
Medium
Report
VolitionRx Limited (NYSE: VNRX) had its "hold" rating re-affirmed by analysts at Benchmark Co..
11/20
03:11 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/16
02:13 am
vnrx
VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
Medium
Report
VolitionRX Ltd (VNRX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... [Yahoo! Finance]
11/14
04:10 pm
vnrx
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update
Medium
Report
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update
11/14
07:26 am
vnrx
VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
Medium
Report
VolitionRX Ltd (VNRX) Q3 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
11/12
02:00 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/8
08:00 am
vnrx
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
High
Report
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
11/6
04:10 pm
vnrx
Volition Appoints Timothy I. Still as Chairman
Medium
Report
Volition Appoints Timothy I. Still as Chairman
11/4
02:09 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/31
08:00 am
vnrx
Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating
Medium
Report
Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating
10/27
02:07 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/19
02:07 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/11
02:08 am
vnrx
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/9
08:00 am
vnrx
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar
Medium
Report
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar
10/3
08:00 am
vnrx
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024
Medium
Report
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024